Puslapis 1 nuo 17 rezultatus
FIELD OF THE INVENTION
The present invention is generally directed to novel compositions and methods for treatment of dermatologic conditions. More particularly, a composition comprising Terpene and cannabidiol (CBD) or derivatives thereof for treating inflammatory skin disorders. Further, the
FIELD OF THE INVENTION
This invention generally relates to chemical engineering and organic chemistry. In alternative embodiments, provided are industrial processes and methods for extracting or removing cannabinoids, flavonoids and terpenes from plant materials such as trichomes. In alternative
FIELD OF THE INVENTION
This invention generally relates to chemical engineering and organic chemistry. In alternative embodiments, provided are industrial processes and methods for extracting or removing cannabinoids, flavonoids and terpenes from plant materials such as trichomes. In alternative
BACKGROUND OF THE INVENTION
Field of the Invention
One or more embodiments of the invention are related to the field of extraction of substances from plant material. More particularly, but not by way of limitation, one or more embodiments of the invention enable a system for producing a
FIELD OF THE INVENTION
The present disclosure relates to methods for the analysis and measurement of cannabis secondary compounds including cannabinoids and terpenes.
BACKGROUND OF THE INVENTION
The requirements for an acceptable cannabis assay have changed dramatically over the years, and the
BACKGROUND
The present disclosure relates generally to extraction processes for naturally-occurring compounds. In particular, extraction processes and methods for cannabinoids and terpenes are described.
Cannabis is a genus of plants that include three species, Cannabis sativa, Cannabis indica, and
FIELD OF THE INVENTION
The present invention relates to the field of plant breeding. In particular, this invention relates specialty cannabis plants, cultivars and varieties, including methods for making and using said cannabis plants and compositions derived thereof.
BACKGROUND OF THE
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority to pending U.S. application Ser. No. 14/561,091 entitled "Transdermal Cannabinoid Formulations", filed Dec. 4, 2014, now U.S. Pat. No. 9,375,417, issued Jun. 28, 2016, the disclosure of which is hereby incorporated by reference
BACKGROUND
The clinical usefulness of the cannabinoids, including 11.sup.9-tetrahydrocannabinol (/1.sup.9-THC), to provide analgesia, help alleviate nausea and emesis, as well as stimulate appetite has been well-recognized. Cannabinoids offer a variety of pharmacological benefits, including, but not
BACKGROUND
The clinical usefulness of the cannabinoids, including .DELTA..sup.9-tetrahydrocannabinol (.DELTA..sup.9-THC), to provide analgesia, help alleviate nausea and emesis, as well as stimulate appetite has been well-recognized. Cannabinoids offer a variety of pharmacological benefits,
BACKGROUND OF THE INVENTION
Field of the Invention
One or more embodiments of the invention are related to the field of extraction of substances from plant material. More particularly, but not by way of limitation, one or more embodiments of the invention enable a method for removing contaminants
BACKGROUND OF THE INVENTION
Field of the Invention
One or more embodiments of the invention are related to the field of extraction of substances from plant material. More particularly, but not by way of limitation, one or more embodiments of the invention enable a method for removing contaminants
FIELD OF THE INVENTION
The invention relates to a process for preparing a concentrated cannabinoid product containing an array of cannabinoids, and optionally terpenes, flavonoids, and other phytoconstituents. The concentrated cannabinoid product can be used in medicinal cannabis treatment
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted electronically in ASCII format and is hereby incorporated by reference in its entirety.
TECHNICAL FIELD
The current inventive technology relates to the field of genetically modified plants. In particular,
FIELD OF THE INVENTION
The present disclosure relates to compositions comprising cannabinoids and melatonin, and formulations and products suitable for administering effective doses of the compositions to a subject.
BACKGROUND OF THE INVENTION
Cannabis, commonly known as marijuana, hemp, and by